Trial Profile
Observational Usage Study of Faslodex in Patients Suffering From Initial Breast Cancer in France.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Feb 2011
Price :
$35
*
At a glance
- Drugs Fulvestrant (Primary)
- Indications Early breast cancer
- Focus Therapeutic Use
- Sponsors AstraZeneca
- 10 Jun 2008 New trial record.